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To determine whether vaccination with live virus vaccines may be etiologi-
cally related to Reye syndrome, we examined 404 cases reported to the Center
for Disease Control. Fifteen of 269 children with Reye syndrome had been 
inoculated with live virus vaccines within 30 days before onset of illness.
Although this temporal relationship may have occurred by chance, seasonal
distribution and clustering of incubation periods suggests that live virus
vaccines may occasionally serve as cofactors in the etiology of Reye syndrome
through undefined mechanisms.
AN instance of Reye syndrome related toI~I
administration of live measles vaccine which
was reported to the Center for Disease Control
(CDC) prompted a search of data on file at
CDC for similar cases. This report summarizes
our findings.
Methods
Reye syndrome was defined as (1) an acute
noninflammatory encephalopathy character-
ized by cerebrospinal fluid (CSF) containing
less than 8 white blood cells (WBC) per mem3
or by histologic sections of brain demonstrat-
ing cerebral edema without meningeai or peri-
vascular inflammation, and (2) evidence of
fatty change of the liver demonstrated by
biopsy or autopsy, or an SCOT or SGPT 3
times normal or a blood ammonia level 1.5
times normal, with (3) no other explanation
for the neurologic or hepatic abnormalities.
We examined report forms of 404 cases of
Reye syndrome. These reports had been filed
between mid-1971 and December 1976 with
either the CDC Viral Diseases Division,
Bureau of Epidemiology, which maintains a
voluntary nationwide reporting system of
Reye syndrome, or with the Immunization
Division, Bureau of State Services, to which
reports of possible vaccine-related illnesses
are sent. Of these forms, 289 contained
responses to a question about &dquo;immunization&dquo;
[sic] in the previous month.
Results
Of these 269 children, 23 were stated to
have received an &dquo;immunization&dquo; within one
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TABLE 1. Cases of Reye Syndrome Temporally As.sr~citated with Live Virus Vaccination
* M = measles vaccine; MMR = live measles, mumps,
rubella vaccine; V = vaccinia virus inoculation; OPV
= live oral polio virus vaccine; DTP = diphtheria and
tetanus toxoids, and killed pertussis vaccine.
t Not vaccinated, but vaccine-derived polioviruses were
cultured from patient.
? Mean for 1974-1976 for all children, 10.3 years.
§ Previously reported.’
~’ Previously reported.&dquo;’
month preceding their illness. Of the 23, four
had received bacterial vaccine (diptheria and
tetanus toxoids and killed pertussis); three
had received an undetermined type of vaccine;
and in one the diagnosis of Reye syndrome
(measles vaccine-associated) was question-
able-the child may have had encephalitis.
There were 14 who had been given a live virus
vaccine within a month before onset of
prodromal symptoms of Reye syndrome; and
one other (Case K, Table 1) who had no history
of receiving any vaccinations but vaccine-
derived polioviruses were cultured from him.
Only the 14 children known to have received
live virus vaccinations and Case K are discussed
in this survey. These 15 cases were distrib-
uted in 1 I states and the District of Columbia;
they occurred at all times of the year (Table l ).
Case His~ory
Case I (Pt. A, Table 1). An 18-month-oid
girl was admitted from the emergency room of a
small community hospital with progression of
fever, vomiting, convulsions, and coma over a 2-day
She received live furthermeasles had  attenuated
measles vaccine 9 days prior to onset of prodromal
symptoms, and also rubella vaccine 45 days prior
to the onset.
WBC count, CSF analysis, and serum electrolyte
levels were within normal limits. While being trans-
ferred to a large referral center on the 4th day of
illness, she suffered a respiratory arrest and was
resuscitated with intravenous urea.
Examination revealed an unconscious child with
normal fundi and hyperflexia of both upper
extremities. The liver edge was palpated 4 cm
below the right costal margin. Her pupils, which
-had been fixed and dilated on arrival, responded
briskly to light within minutes of the urea infusion.
Laboratory studies included a WBC count of
12,000 with a marked left shift, serum ammonia
0.3 mg/dl (control, 0.2 mg/dl), SGPT 262 units,
SGOT 209 units, total bilirubin 0.3 rrrg/dl, and
2-hour urinary amylase 90 units. Skull films and
carotid arteriograms were normal. The electro-
encephalogram was interpreted as being compati-
ble with Reye syndrome, Grade III on the scale of
Aoki and Lombroso.~ Liver biopsy studies showed
fatty infiltration without significant inflammatory
response and electron micrographs revealed
swollen mitochondria, both interpreted as con-
sistent with Reye syndrome.
An intracranial pressure monitor was placed
through a burr hole, and intravenous urea adminis-
tered for repeated &dquo;spikes&dquo; in intracranial pressure.
Her neurologic status remained poor, however,
and at the time of discharge, 66 days later, she
suffered from marked spasticity, optic atrophy,
and apparent severe intellectual deterioration.
Virologic studies performed at the referral
center laboratory included negative cultures of
throat, nasopharynx, CSF, rectal swab, urine, and
liver tissue. The following indirect immuno-
fluorescent antibody (IFA) studies were negative:
screen of the CSF for antibodies to V-Z virus,
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rubella, mumps, and herpes simplex. Serum EB
virus titer (IFA) was less than 1:8. Serum rubella
titers (IFA) were 1:16 on the 4th, 13th, and 24th
days of clinical illness. On the same days, serum
rubeola titers (IFA) were <1:8, 1:64, and 1:32.
Complement fixation titers of acute and conva-
lescent sera examined by the Michigan Department
of Health, Bureau of Disease Control and Labora-
tory Services, confirmed rubeola seroconversion.
There was no evidence of seroconversion to
St. Louis Encephalitis virus, LCM virus, herpes
simplex, V-Z virus, mumps, parainfluenza 1, 2, and
3, influenza A and B, polioviruses l, 2, and 3, Myco-
plasma pneumoniae, or the LGV agent.
Discussion
Reye syndrome following vaccination with a
live virus has been reported infrequently. Two
possible cases of measles vaccine-associated
Reye syndrome were described by Landrigan
and Witter one case of which is included here
(Case B, Table l ~. The other child did not
meet our case definition. Reviews of the
Unites States experience with vaccinia virus
inoculation by Neff et al. and Lane et at.5 re-
vealed no instances of Reye syndrome,
although in the earliest of these series marked
cerebral edema was noted in all four of the
autopsied cases of &dquo;postvaccinal encephalitis.&dquo;
In a later series, at least two children had
illnesses similar to Reye syndrome. A case of
Reye syndrome associated with vaccine-
derived poliovirus was reported in a 7-year-
old contact by Brunberg and Bell. 6
Assuming that the inactive components of
the vaccines play no role in the etiology
of Reye syndrome, there are at least 3 reason-
able explanations of the temporal relationship
between live virus vaccination and Reye
syndrome: (1) It is coincidental. (2) The virus
in the vaccine is the sole infectious agent
with the disease. (3) The virus in
the vaccine acts as an etiologic cofactor in con-
junction with one or more other infectious
agents.
When exploring these possibilities, we
looked at the prevalence of viral diseases in
the communities at the time of illness. With
6 of the 15 cases, other viruses reported in
the past to have preceded Reye syndrome
were known to have been recently present,
including influenza B in two instances and
influenza A in another. Perhaps these or other
undetected viruses played a role in the devel-
opment of Reye syndrome in these patients.
Furthermore, 5 of the 15 children had mild
respiratory symptoms preceding the onset of
neurologic symptoms; one during the time
when influenza B was prevalent in his com-
munity. This is suggestive evidence that other
etiologic agents may have been involved in at
least some of the cases. However, only 3 of the
15 live vaccine-associated cases occurred in the
3-month period (January through March)
during which 76 per cent of the Reye
syndrome cases reported to CDC in 1974-
1976 occurred, p < .0001, chi-square, ldf,
(Table 1).
There was apparent clustering of disease
onset in the second week after the vaccination.
Prodromal symptoms of Reye syndrome
began in 11 instances between 7 and 12 days
after the vaccination. If the three cases with
unknown vaccination dates are distributed
randomly throughout the 30.46 days of the
average month, the likelihood of the other
I cases’ clustering within any 7-day period is
not great (p < .01, binomial expansion). If
recall bias were operative, one would expect
a more direct relationship between recentness
of vaccination and onset of Reye syndrome.
Thus, it is difficult to reject the hypothesis
that live virus vaccines may serve as cofactors
in the occurrence of Reye syndrome, though
the available data do not determine whether
such a relationship might be secondary solely
to primary infection, or to the interaction of
the vaccine virus with other infectious agents
acquired naturally.
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